探讨妇科影像报告与数据系统(Gynecology Imaging Reporting and Data System,GI-RADS)结合人附睾蛋白4(human epididymis protein 4,HE4)和糖类抗原125 (carbohydrate antigen 125,CA125)在卵巢恶性肿瘤诊断中的应用价值。
To explore the value of gynecologic imaging reporting and data system (GI-RADS) with human epididymis protein 4 (HE4) and carbohydrate antigen 125 (CA125) in the preoperative differentiation between malignant and benign ovarian tumors.
Methods:
A total of 114 patients with suspected adnexal mass were selected from Feb. 2016 to Feb. 2018. Ultrasonographic diagnosis was based on the GI-RADS classification. Serum concentration of HE4 and CA125 was measured for each patient before surgical operation
. The results of combined examination were compared with the final pathological diagnosis.
Results:
The sensitivity
specificity
positive predictive value and negative predictive value of GI-RADS reporting system combined with HE4 and CA125 were 95.9%
87.7%
85.5% and 96.6%
respectively.
Conclusion:
The GI-RADS classification combined with HE4 and CA125 performs well in identifying malignant ovarian tumors
enhances communication between sonographers and clinicians
and plays an important role in guiding clinical decision making and improving patient care.
Value of 18F-fluorodeoxyglucose PET/CT imaging combined with serum carbohydrate antigen 125 and human epididymis protein 4 detection in diagnosis of ovarian malignancy
Value of combination of 18F-fluorodeoxyglucose PET/CT and serum carbohydrate antigen125 and human epididymis protein4 in diagnosis of recurrent or metastatic ovarian cancers
Ultrasound diagnosis and misdiagnosis of endometrial polyps
Clinical study on two-dimensional hysterosalpingo-contrast sonography and X-ray hysterosalpingography
Related Author
FAN Wei
LI Qiwen
LONG Wen
XIAO zizheng
ZHANG Yarui
HU Yingying
ZHENG Rongliang
XU Junyan
Related Institution
Department of Nuclear Medicine, Sun Yat-sen University Cancer Center
State Key Laboratory of Oncology in South China
Department of Nuclear Medicine, The Second Affiliated Hospital of Anhui Medical University
Department of Nuclear Medicine, Fudan University Shanghai Cancer Center
Shanghai Engineering Research Center for Molecular Imaging Probes